Home
OSE Immunotherapeutics SA

OSE Immunotherapeutics SA Market Share Analysis for June 2026

POLITIQUE RELATIVE À LA PROTECTION DES DONNÉES À CARACTÈRE PERSONNEL 1. Nom et coordonnées de la société et du Délégué à la Protection des Données Ces informations relatives à la protection des données sont applicables aux procédures de traitement de données observées par : OSE Immunotherapeutics SA (ci-après désignée « OSE Immunotherapeutics ») 22 boulevard […]

Health > Biotechnology and Pharmaceuticals

Domainose-immuno.com

Year Founded2012

Employees51 - 200

Annual Revenue$15M - $25M

OSE Immunotherapeutics SA

OSE Immunotherapeutics SA (including company regionals)

ose-immuno.com

See more website traffic and engagement information

OSE Immunotherapeutics SA Revenue up to June 2026 is 15M - 25M

revenue generated by OSE Immunotherapeutics SA top domains

OSE Immunotherapeutics SA top domains revenue over 3 years

Revenue for OSE Immunotherapeutics SA top domains

ose-immuno.com15M - 25M

See more with Sales Intelligence

Total visits to OSE Immunotherapeutics SA's top domains

Understand OSE Immunotherapeutics SA market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ose-immuno.com5.5K

See more with Sales Intelligence

Avg. visit duration in OSE Immunotherapeutics SA's top domains

Analyze OSE Immunotherapeutics SA engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ose-immuno.com00:00:49

See more with Sales Intelligence

Avg. pageviews on OSE Immunotherapeutics SA's top domains

See how OSE Immunotherapeutics SA keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ose-immuno.com1.75

See more with Sales Intelligence

OSE Immunotherapeutics SA top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by OSE Immunotherapeutics SA

These are the website technologies, by industry, used by OSE Immunotherapeutics SA top domains

Payment & Currencies (11)

Cart Functionality

eCommerce (5)

OpenCart

Advertising (4)

LinkedIn Advertiser

Conversion & Analytics (3)

Google Analytics

More Technologies

13

See all

News & Signals from OSE Immunotherapeutics SA

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOse Immuno attended event Annual General Meeting on Apr 23rd '26.NANTES, France, June 3, 2026 - 8:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (the "Company"), announced that it will hold its Annual General Meeting on June 24, 2026, at 10:00 am CET at Jones Day's offices located 2 rue Saint Florentin, 75001 Paris, France.

NewsOse Immuno partnered with Veloxis Pharmaceuticals, Inc. on Jul 1st '21.OSE Immunotherapeutics subsequently licensed the technology from INSERM and, in 2021, entered an exclusive licensing and co-development agreement with Veloxis Pharmaceuticals - a transplant-focused specialty company and subsidiary of Asahi Kasei Corporation - which assumed lead development responsibility, particularly for clinical advancement in the United States.

NewsOse Immuno attended event ASCO 2026 Meeting on Apr 23rd '26.OSE Immunotherapeutics announces presentation of TEDOVA Phase 2 topline results of Tedopi(R) in Ovarian Cancer at the ASCO 2026 Meeting.